Publications by authors named "Virginia D Steen"

Claim this Profile
C
Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Dinesh Khanna, Cathie Spino, Donald P Tashkin, Elana J Bernstein, Jonathan Goldin, Virginia D Steen

ACR Open Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts.
Iqtidar Hanif, Shervin Assassi, Maureen D Mayes, Zsuzsanna H McMahan, Meng Zhang, Virginia D Steen

Arthritis Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis.
Hana Sabanovic, John D Pauling, Murray Baron, Laurence Clemens, Francesco Del Galdo, Virginia D Steen

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type III and type VI collagen neoepitopes are associated with disease severity in systemic sclerosis.
Ali Y Ayla, Elana J Bernstein, Meng Zhang, John M VanBuren, Flavia V Castelino, Virginia D Steen

J Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.
Yiming Luo, Shervin Assassi, Maureen D Mayes, Tracy M Frech, Virginia D Steen

Ann Am Thorac Soc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study.
Monique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, Stefano Di Donato, Antonio Carriero, Virginia D Steen

Lancet Rheumatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis.
Jeong Min Yu, John M VanBuren, Angela Child, Jessica S Alvey, Lisa A Mandl, Virginia D Steen

J Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial Biomarkers of Systemic Sclerosis-Associated Pulmonary Hypertension.
Matthew R Lammi, Kathleen D Kolstad, Lesley Ann Saketkoo, Avani Khatri, Paul J Utz, Virginia D Steen

Arthritis Care Res (Hoboken)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.
Yiming Luo, Jessica K Gordon, Jiehui Xu, Kathleen D Kolstad, Lorinda Chung, Virginia D Steen

Rheumatology (Oxford)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Characteristics of Patients With Systemic Sclerosis Fulfilling the 2019 EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
Ronald D Bass, Duncan F Moore, Virginia D Steen

Arthritis Care Res (Hoboken)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gerald P Rodnan.
Virginia D Steen, Thomas A Medsger

Rheum Dis Clin North Am· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
Larabe Farrukh, Virginia D Steen, Lee Shapiro, Swati Mehta

Semin Arthritis Rheum· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.
Sarah Luebker, Tracy M Frech, Shervin Assassi, Brian Skaug, Jessica K Gordon, Virginia D Steen

Rheumatology (Oxford)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.
Sarah Luebker, Tracy M Frech, Shervin Assassi, Jessica K Gordon, Elana J Bernstein, Virginia D Steen

Clin Exp Rheumatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental Health Considerations in Chronic Disease: What Is the Best Approach for Supporting a Scleroderma Patient?
Nancy Lazar, Virginia D Steen

Rheum Dis Clin North Am· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire.
Lesley Ann Saketkoo, Jessica K Gordon, Kim Fligelstone, Anne Mawdsley, Humza A Chaudhry, Virginia D Steen

Rheum Dis Clin North Am· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort.
Michael Hughes, Suiyuan Huang, Juan Jose Alegre-Sancho, Patricia E Carreira, Merete Engelhart, Virginia D Steen

Rheumatology (Oxford)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Franck F Rahaghi, Vivien M Hsu, Robert J Kaner, Maureen D Mayes, Ivan O Rosas, Virginia D Steen

Respir Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States.
Elana J Bernstein, Shervin Assassi, Flavia V Castelino, Lorinda Chung, Chase Correia, Virginia D Steen

ACR Open Rheumatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry.
Kimberly Showalter, Laura C Pinheiro, Deanna Jannat-Khah, Irina Sobol, Jackie Szymonifka, Virginia D Steen

Rheumatology (Oxford)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension.
Kathleen D Kolstad, Avani Khatri, Michele Donato, Sarah E Chang, Shufeng Li, Virginia D Steen

Arthritis Res Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease.
Shervin Assassi, Ning Li, Elizabeth R Volkmann, Maureen D Mayes, Dennis Rünger, Virginia D Steen

Arthritis Rheumatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall mortality.
Duncan F Moore, Virginia D Steen

J Scleroderma Relat Disord· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.
Lorinda Chung, Cathie Spino, Richard McLain, Sindhu R Johnson, Christopher P Denton, Virginia D Steen

Lancet Rheumatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Disparities in Systemic Sclerosis.
Duncan F Moore, Virginia D Steen

Rheum Dis Clin North Am· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis